Vivek
Middle Name
Pratap
Singh, Ph.D.
Middle Name
Pratap
Picture

Positions
- Assistant Professor of Surgery
-
Division of Cardiothoracic Surgery
Baylor College of Medicine
Houston, Texas
Addresses
- BCM-Jewish Institute for Research (Lab)
-
Room: BCMD-R412
Houston, TX 77030
United States
Phone: (713) 798-3227
viveks@bcm.edu
Education
- PhD from Sanjay Gandhi Post Graduate Institute of Medical Sciences
- 01/2006 - Lucknow, Uttar Pradesh India
- Medical Genetics
- MS from Dr. Ram Manohar Lohia, Avadh University
- 05/2001 - Faizabad, Uttar Pradesh India
- Biochemistry
Honors & Awards
- Best Junior Faculty Award
- 5th Annual Cardiovascular Research Institute (CVRI) Symposium
- Baylor College of Medicine, Houston, TX, USA (04/2017)
- Outstanding New Investigator Award-Council of Basic Cardiovascular Sciences
- American Heart Association (AHA) Scientific Session, Las Vegas, USA (07/2014)
- Early Career Investigator Award, Council of Basic Cardiovascular Sciences
- American Heart Association Scientific Session (08/2014 - 08/2014)
- Outstanding Investigator Award -North American Section Meeting (pathology and treatment of heart failure)
- International Society of Heart Research (ISHR), Banff, Canada (05/2012)
- American Heart Association Fellowship Award-Great-Rivers Affiliate
- American Heart Association, USA (07/2010 - 06/2012)
- Young Investigator's Award-Cardiac Regulatory Mechanisms
- Gordon Research Conference (GRC), New London, New Hampshire, USA (06/2010)
- Best Research Award
- Scott and White Hospital, Texas AandM University, Texas, USA (05/2009)
- Outstanding Research Award-Internal Medicine Day
- Scott and White Hospital, Texas AandM University, Texas, USA (06/2008)
- Outstanding Research Award-Cardiovascular Research Retreat
- Texas AandM University, Health Science Center, Texas, USA (04/2007)
- Outstanding Research Award-Cardiovascular Research Retreat
- Texas AandM University, Health Science Center, Texas, USA (03/2006)
- University Gold Medalist-Master of Science
- Dr. R.M.L. Avadh University Faizabad, Uttar Pradesh, INDIA (05/2001)
Professional Interests
- Hypertension/ Arrhythmia • Ischemia and Reperfusion • Diabetic Cardiomyopathy • Cellular Reprogramming • Diabetes/obesity • Gene Therapy
Professional Statement
Dr. Vivek Singh’s research focuses on molecular and genetic mechanisms that mediate myocardial remodeling and heart failure, and the development of new drug and gene-based therapies for heart disease. The research Dr. Singh accomplished during his doctoral and post-doctoral tenures has significantly contributed to a better understanding of the biochemical, molecular, and genetic mechanisms that regulate cardiac function. A significant amount of Dr. Singh work has focused on the renin-angiotensin system and its direct involvement in mediating cell growth in the heart. Dr. Singh has characterized an intracardiac intracellular renin-angiotensin system and has shown that the precursor genes of the system significantly modulate a number of pathological conditions such as diabetic cardiomyopathy. Recently, he identified the genetic biomarkers predisposing to sudden death in heart failure patients and studied the underlying mechanism of ventricular arrhythmias and increased risk of sudden cardiac death in dilated cardiomyopathy. More recently, Dr. Singh examined key developmental cardiac regulators, known as transcription factors GMT (GATA4, MEF2C and TBX5), that reprogram cardiac fibroblasts into functional, beating cardiomyocytes, a novel, promising gene therapy strategy to treat heart failure. Dr. Vivek has a vast experience working on cardiac myocytes and fibroblast both in vitro and in vivo, especially in cardiac electrophysiology. The overall summary of his work is to better understand the molecular signaling pathways, to identify genetic biomarkers and gene regulatory events that modulate cardiac function, and to better understand how these mechanisms may contribute to the development of interventions to modulate heart failure.Websites
Selected Publications
- Vivek P Singh, Jaya Pratap Pinnamaneni , Aarthi Pugazenthi , Deepthi Sanagasetti, Megumi Mathison , Kai Wang , Jianchang Yang , Todd K Rosengart "Enhanced Generation of Induced Cardiomyocytes Using a Small-Molecule Cocktail to Overcome Barriers to Cardiac Cellular Reprogramming." JAHA. 2020 June 16; 16 (9(12)): e015686. Pubmed PMID: 32500803
- Ravi K Ghanta, Samira Aghlara-Fotovat, Aarthi Pugazenthi, Christopher T Ryan, Vivek P Singh, Megumi Mathison, Maria I Jarvis, Sudip Mukherjee, Andrea Hernandez , Omid Veiseh "Immune-modulatory alginate protects mesenchymal stem cells for sustained delivery of reparative factors to ischemic myocardium." Biomaterial Science. 2020 September 15; 8 (18): 5061-5070. Pubmed PMID: 32797143
- Patel V, Singh VP, Pinnamaneni JP, Sanagasetti D, Olive J, Mathison M, Cooney A, Flores ER, Crystal RG, Yang J, Rosengart TK. "p63 Silencing induces reprogramming of cardiac fibroblasts into cardiomyocyte-like cells.." J Thorac Cardiovasc Surg.. 2018 April 13; : S0022-5223(18)30986-3.. Pubmed PMID: 29716728
- Chiu HS, Somvanshi S, Patel E, Chen TW, Singh VP, Zorman B, Patil SL, Pan Y, Chatterjee SS; Cancer Genome Atlas Research Network, Sood AK, Gunaratne PH, Sumazin P. "Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context." Cell Report. 2018 April 3; 23 (1): 297-312.e12. Pubmed PMID: 29617668
- Yang L, Liu L, Gao H, Pinnamaneni JP, Sanagasetti D, Singh VP, Wang K, Mathison M, Zhang Q, Chen F, Rosengart T, Yang J. "The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis.." J Hematol Oncol.. 2017 October 3; 10 (1): Pubmed PMID: 28974232
- Pollak AJ, Haghighi K, Kunduri S, Arvanitis DA, Bidwell PA, Liu GS, Singh VP, Gonzalez DJ, Sanoudou D, Wiley SE, Dixon JE, Kranias EG. "Phosphorylation of serine96 of histidine-rich calcium-binding protein by the Fam20C kinase functions to prevent cardiac arrhythmia.." Proc Natl Acad Sci U S A. 2017 August 7; : Pubmed PMID: 28784772
- Pinnamaneni JP, Sanagasetti D, Singh VP "Cardiac Regeneration: Challenges and Clinical Applications." J surg. 2017 4 (J120):
- Mathison M, Singh VP, Sanagasetti D, Yang L, Pinnamaneni JP, Yang J, Rosengart TK. "Cardiac reprogramming factor Gata4 reduces postinfarct cardiac fibrosis through direct repression of the profibrotic mediator snail.." J Thorac Cardiovasc Surg. 2017 June 21; 17 : 31354-5. Pubmed PMID: 28711329
- Singh VP, Mathison M, Patel V, Sanagasetti D, Gibson BW, Yang J, Rosengart TK. "MiR-590 Promotes Transdifferentiation of Porcine and Human Fibroblasts Toward a Cardiomyocyte-Like Fate by Directly Repressing Specificity Protein 1.." J Am Heart Assoc.. 2016 November 10; 5 (11): Pubmed PMID: 27930352
- Singh VP*, Mathison M*, Chiuchiolo MJ, Sanagasetti D, Mao Y, Patel VB, Yang J, Kaminsky SM, Crystal RG, Rosengart TK "In situ reprogramming to transdifferentiate fibroblasts into cardiomyocytes using adenoviral vectors: Implications for clinical myocardial regeneration.." J Thorac Cardiovasc Surg.. 2016 September 23; 16 (1. [*equal contribution, cited first]): Pubmed PMID: 27773576
- Patel V, Mathison M, Singh VP, Yang J, Rosengart TK. "Direct Cardiac Cellular Reprogramming for Cardiac Regeneration.." Curr Treat Options Cardiovasc Med.. 2016 September 11; 18 (9): Pubmed PMID: 27554127
- Haghighi K, Pritchard TJ, Liu GS, Singh VP, Bidwell P, Lam CK, Vafiadaki E, Das P, Ma J, Kunduri S, Sanoudou D, Florea S, Vanderbilt E, Wang HS, Rubinstein J, Hajjar RJ, Kranias EG. "Human G109E-inhibitor-1 impairs cardiac function and promotes arrhythmias.." J Mol Cell Cardiol.. 2015 December ; : 349-359. Pubmed PMID: 26455482
- Mathison M, Singh VP, Gersch RP, Ramirez MO, Cooney A, Kaminsky SA, Chiuchiolo MJ, Nasser A, Yang J, Crystal RG, Rosengart TK. "Triplet polycistronic vectors encoding Gata4, Mef2c and Tbx5 enhance postinfarct ventricular functional improvement compared with singlet vectors." The Journal of thoracic and cardiovascular su. 2014 14 : S0022-5223. Pubmed PMID: 24755332
- Rubinstein J, Lasko VM, Koch SE, Singh VP, Carreira V, Robbins N, Patel AR, Jiang M, Bidwell P, Kranias EG, Jones WK, Lorenz JN. "Novel role of transient receptor potential vanilloid 2 in the regulation of cardiac performance.." Am J Physiol Heart Circ Physiol.. 2014 February ; 306 (4): H574-84.. Pubmed PMID: 24322617
- Singh VP, Rubinstein J, Arvanitis DA, Ren X, Gao X, Haghighi K, Gilbert M, Iyer VR, Kim DH, Cho C, Jones K, Lorenz JN, Armstrong CF, Wang HS, Gyorke S, Kranias EG. "Abnormal calcium cycling and cardiac arrhythmias associated with the human Ser96Ala genetic variant of histidine-rich calcium-binding protein.." J Am Heart Assoc.. 2013 October 14; 2 (5): e000460.. Pubmed PMID: 24125847
- Basford JE, Koch S, Anjak A, Singh VP, Krause EG, Robbins N, Weintraub NL, Hui DY, Rubinstein J. "Smooth muscle LDL receptor-related protein-1 deletion induces aortic insufficiency and promotes vascular cardiomyopathy in mice.." PLoS One.. 2013 November 29; 8 (11): e82026.. Pubmed PMID: 24312398
Funding
- Cell Plasticity-Based Reprogramming Strategies to Enhance Human Myocardial Regeneration - #HL 152280 (04/01/2020 - 03/31/2024) Grant funding from NIH R01-Co Investigator
- This grant supports research studies to investigate cell plasticity-based reprogramming myocardial regeneration
- In situ Cardiac Infarct Cellular Reprogramming - #HL121294-01A1 (09/01/2015 - 02/28/2019) Grant funding from NIH/NHLBI R01-Co Investigator
- Reprogramming cardiac fibroblasts into cardiac-like myocytes in vitro/in vivo for potential use in regenerative medicine
- (AHA) (07/01/2010 - 06/30/2012) Grant funding from American Heart Association
Log In to edit your profile